FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hubert Scharnagl

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

Cells, Cultured

Co-author Network

Publications

TOP 3
Ivana Sreckovic; Tatjana Stojakovic; Ruth Birner-Gruenberger; Gernot Desoye; Michael Holzer; Uwe Lang; Gunther Marsche; Britta Obrist; Sonia Philipose; Hubert Scharnagl; Monika Scholler; Christian Wadsack
Distinct composition of human fetal HDL attenuates its anti-oxidative capacity.
Andreas Schneider; Markus P Schneider; Christoph Wanner; Alan G Jardine; Hubert Scharnagl; Christiane Drechsler
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes.
Juergen Falkensammer; Gustav Fraedrich; Andreas Frech; Simon Gasteiger; Andreas Greiner; Hubert Scharnagl; Tatjana Stojakovic; Markus Stühlinger; Kurt Huber
Elevated baseline hs-cTnT levels predict exercise-induced myocardial ischemia in patients with peripheral arterial disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hubert Scharnagl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ivana Sreckovic; Tatjana Stojakovic; Ruth Birner-Gruenberger; Gernot Desoye; Michael Holzer; Uwe Lang; Gunther Marsche; Britta Obrist; Sonia Philipose; Hubert Scharnagl; Monika Scholler; Christian Wadsack
Distinct composition of human fetal HDL attenuates its anti-oxidative capacity.
Biochimica et biophysica acta 2013;1831(4):737-46.
2013: Andreas Schneider; Markus P Schneider; Christoph Wanner; Alan G Jardine; Hubert Scharnagl; Christiane Drechsler
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes.
BMC nephrology 2013;14():67.
2012: Juergen Falkensammer; Gustav Fraedrich; Andreas Frech; Simon Gasteiger; Andreas Greiner; Hubert Scharnagl; Tatjana Stojakovic; Markus Stühlinger; Kurt Huber
Elevated baseline hs-cTnT levels predict exercise-induced myocardial ischemia in patients with peripheral arterial disease.
Clinica chimica acta; international journal of clinical chemistry 2012;413(19-20):1678-82.
2012: Gernot Schilcher; Tatjana Stojakovic; Joerg H Horina; Werner Ribitsch; Alexander R Rosenkranz; Hubert Scharnagl; Hans-Dietrich Polaschegg
Trisodium citrate induced protein precipitation in haemodialysis catheters might cause pulmonary embolism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(7):2953-7.
2012: Claudia D Fuchs; Judith Gumhold; Guenter Haemmerle; Emina Halilbasic; Harald Koefeler; Pooja Kumari; Marion J Pollheimer; Hubert Scharnagl; Dagmar Silbert; Tatjana Stojakovic; Thierry Claudel; Michael Trauner
Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice.
Hepatology (Baltimore, Md.) 2012;56(1):270-80.
2012: My Svensson; Gisela Weihrauch; Dag Olav Dahle; Harald Dobnig; Bengt Fellström; Alan Jardine; Winfried März; Geir Mjøen; Hubert Scharnagl; Hallvard Holdaas
Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(6):2571-5.
2012: Csilla Putz-Bankuti; Hubert Scharnagl; Barbara Obermayer-Pietsch; Thomas R Pieber; Stefan Pilz; Tatjana Stojakovic; Michael Trauner; Rudolf E Stauber
Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(5):845-51.
2012: Andreas Schneider; Markus P Schneider; Christoph Wanner; Christiane Drechsler; Vera Krane; Detlef H Krieter; Hubert Scharnagl
The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(1):52-9.
2011: Dag Olav Dahle; Bengt Fellström; Tanja Grammer; sadollah abedini; Ingar Holme; Alan Jardine; Winfried März; Geir Mjøen; Gudrun E Norby; Björn Oqvist; Hubert Scharnagl; Gisela Weihrauch; Hallvard Holdaas
Inflammation-associated graft loss in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2011;26(11):3756-61.
2011: Thomas Seifert-Held; Nicole E Simmet; Tatjana Stojakovic; Franz Fazekas; Thomas Gattringer; Thomas Pekar; Hubert Scharnagl; Maria K Storch
Circulating Dickkopf-1 in acute ischemic stroke and clinically stable cerebrovascular disease.
Atherosclerosis 2011;218(1):233-7.
2011: Thomas Gary; Franz Hafner; Ernst Pilger; Peter Rief; Hubert Scharnagl; Tatjana Stojakovic; Harald Froehlich; Marianne Brodmann
Lipoproteins and the development of restenosis after stent implantation in the superficial femoral artery in patients with peripheral artery disease.
Cardiovascular and interventional radiology 2011;34(4):739-43.
2011: Winfried März; Eberhard Ritz; Hubert Scharnagl; Tatjana Stojakovic; Christoph Wanner; Karl Winkler; Christiane Drechsler; Bernd Genser; Tanja B Grammer; Hallvard Holdaas; Ingar Holme; Vera Krane
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(6):1316-25.
2010: Andreas Tomaschitz; Winfried Maerz; Stefan Pilz; Eberhard Ritz; Hubert Scharnagl; Wilfried Renner; Bernhard O Boehm; Astrid Fahrleitner-Pammer; Gisela Weihrauch; Harald Dobnig
Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
Journal of the American College of Cardiology 2010;55(19):2171-80.
2010: Peter James Mullen; Barbara Lüscher; Hubert Scharnagl; Stephan Krähenbühl; Karin Brecht
Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy.
Biochemical pharmacology 2010;79(8):1200-9.
2010: Tatjana Stojakovic; A de Campo; Hubert Scharnagl; Harald Sourij; I Schmölzer; Thomas C Wascher; Winfried März
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.
European journal of clinical investigation 2010;40(3):187-94.
2010: Tatjana Stojakovic; Thierry Claudel; Csilla Putz-Bankuti; Günter Fauler; Hubert Scharnagl; Martin Wagner; Harald Sourij; Rudolf E Stauber; Karl Winkler; Winfried März; Thomas C Wascher; Michael Trauner
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
Atherosclerosis 2010;209(1):178-83.
2010: Tatjana Stojakovic; Hubert Scharnagl; Michael Trauner; Burkert Pieske; Britta Wellnitz; Ursula Seelhorst; Dieter Schilling; Bernhard R Winkelmann; Bernhard O Boehm; Winfried März
Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study.
Atherosclerosis 2010;208(2):564-71.
2010: Thomas Gary; Franz Hafner; Harald Froehlich; Tatjana Stojakovic; Hubert Scharnagl; Ernst Pilger; Marianne Brodmann
High factor VIII activity, high plasminogen activator inhibitor 1 antigen levels and low factor XII activity contribute to a thrombophilic tendency in elderly venous thromboembolism patients.
Acta haematologica 2010;124(4):214-7.
2008: Karl Winkler; Michael M Hoffmann; Ursula Seelhorst; Britta Wellnitz; Bernhard O Boehm; Bernhard R Winkelmann; Winfried März; Hubert Scharnagl
Apolipoprotein A-II Is a negative risk indicator for cardiovascular and total mortality: findings from the Ludwigshafen Risk and Cardiovascular Health Study.
Clinical chemistry 2008;54(8):1405-6.
2008: Harald Dobnig; Stefan Pilz; Hubert Scharnagl; Wilfried Renner; Ursula Seelhorst; Britta Wellnitz; Jürgen Kinkeldei; Bernhard O Boehm; Gisela Weihrauch; Winfried Maerz
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.
Archives of internal medicine 2008;168(12):1340-9.
2008: Christoph Castellani; Tatjana Stojakovic; Martin Cichocki; Hubert Scharnagl; Wolfgang Erwa; Anton Gutmann; Annelie-Martina Weinberg
Reference ranges for neuroprotein S-100B: from infants to adolescents.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(9):1296-9.
2007: Stefan Pilz; Hubert Scharnagl; Beate Tiran; Britta Wellnitz; Ursula Seelhorst; Bernhard O Boehm; Winfried März
Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography.
European heart journal 2007;28(22):2763-9.
2007: Tatjana Stojakovic; Csilla Putz-Bankuti; Günter Fauler; Hubert Scharnagl; Martin Wagner; Vanessa Stadlbauer; Gerald C Gurakuqi; Rudolf E Stauber; Winfried März; Michael Trauner
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2007;46(3):776-84.
2007: Tatjana Stojakovic; Hubert Scharnagl; Winfried März; Bernhard R Winkelmann; Bernhard O Boehm; Otto Schmut
Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion.
Clinica chimica acta; international journal of clinical chemistry 2007;382(1-2):77-81.
2007: Hubert Scharnagl; Tatjana Stojakovic; K Winkler; S Rosinger; Winfried März; Bernhard O Boehm
The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2007;115(6):372-5.
2007: C Mayer; H J Gruber; E M Landl; Sabine Pailer; Hubert Scharnagl; Martie Truschnig-Wilders; Winfried März
Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion.
International journal of clinical pharmacology and therapeutics 2007;45(6):319-27.
2007: Steffen Böhler; Hubert Scharnagl; F Freisinger; Tatjana Stojakovic; Heide Glaesmer; Jens Klotsche; Lars Pieper; David Pittrow; Wilhelm Kirch; H Schneider; Günter K Stalla; Hendrik Lehnert; Andreas M Zeiher; Sigmund Silber; Uwe Koch; Günther Ruf; Winfried März; Hans-Ulrich Wittchen
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany.
Atherosclerosis 2007;190(2):397-407.
2007: Juergen Falkensammer; Tatjana Stojakovic; Kurt Huber; Angelika Hammerer-Lercher; Ingrid Gruber; Hubert Scharnagl; Gustav Fraedrich; Wolfram Santner; Michael Schocke; Andreas Greiner
Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007;45(4):535-40.
2006: Stefan Pilz; Hubert Scharnagl; Beate Tiran; Ursula Seelhorst; Britta Wellnitz; Bernhard O Boehm; Juergen R Schaefer; Winfried März
Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease.
The Journal of clinical endocrinology and metabolism 2006;91(7):2542-7.
2006: Hubert Scharnagl; Monika Vogel; Claudia Abletshauser; Franz Freisinger; Tatjana Stojakovic; Winfried März
Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration.
Cardiology 2006;106(4):241-8.
2005: Natalie Khuseyinova; Armin Imhof; Dietrich Rothenbacher; Gerlinde Trischler; Silke Kuelb; Hubert Scharnagl; Winfried Maerz; Hermann Brenner; Wolfgang Koenig
Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis.
Atherosclerosis 2005;182(1):181-8.
2005: Stefan Pilz; Renate Horejsi; Reinhard Möller; Gunter Almer; Hubert Scharnagl; Tatjana Stojakovic; Roumiana Dimitrova; Gisela Weihrauch; Martin Borkenstein; Winfried Maerz; Konrad Schauenstein; Harald Mangge
Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin.
The Journal of clinical endocrinology and metabolism 2005;90(8):4792-6.
2005: Karl Winkler; Bernhard R Winkelmann; Hubert Scharnagl; Michael M Hoffmann; Andrea Busse Grawitz; Markus Nauck; Bernhard O Böhm; Winfried März
Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study.
Circulation 2005;111(8):980-7.
2005: Wilfried Renner; Markus Nauck; Bernhard R Winkelmann; Michael M Hoffmann; Hubert Scharnagl; Volker Mayer; Bernhard O Boehm; Winfried März
Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.
Journal of molecular medicine (Berlin, Germany) 2005;83(3):235-9.
2005: Hubert Scharnagl; Winfried März
New lipid-lowering agents acting on LDL receptors.
Current topics in medicinal chemistry 2005;5(3):233-42.
2004: Winfried März; Hubert Scharnagl; Michael M Hoffmann; Bernhard O Boehm; Bernhard R Winkelmann
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study).
European heart journal 2004;25(23):2109-19.
2004: Winfried März; Hubert Scharnagl; Karl Winkler; Andreas Tiran; Markus Nauck; Bernhard O Boehm; Bernhard R Winkelmann
Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
Circulation 2004;110(19):3068-74.
2004: Tatjana Stojakovic; Hubert Scharnagl; Winfried März
ApoE: crossroads between Alzheimer's disease and atherosclerosis.
Seminars in vascular medicine 2004;4(3):279-85.
2004: Hubert Scharnagl; K Winkler; S Mantz; Manfred W Baumstark; H Wieland; Winfried März
Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2004;112(5):269-77.
2004: Hubert Scharnagl; Gudula Petersen; Markus Nauck; Alexander T Teichmann; Heinrich Wieland; Winfried März
Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism.
Contraception 2004;69(2):105-13.
2004: Hubert Scharnagl; Manfred Kist; Andrea Busse Grawitz; Wolfgang Koenig; Heinrich Wieland; Winfried März
Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol.
The American journal of cardiology 2004;93(2):219-20.
2003: Armin Imhof; Dietrich Rothenbacher; Natalie Khuseyinova; Albrecht Hoffmeister; Winfried Maerz; Markus Nauck; Hubert Scharnagl; Wolfgang Koenig; Hermann Brenner
Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2003;10(5):362-70.
2003: André R Miserez; Hubert Scharnagl; Patrick Y Muller; R Mirsaidi; H B Stähelin; Andreas U Monsch; Winfried März; Michael M Hoffmann
Apolipoprotein E3Basel: new insights into a highly conserved protein region.
European journal of clinical investigation 2003;33(8):677-85.
2003: Nikolaus Marx; Johannes Froehlich; Laila Siam; Jochen Ittner; Gerhard Wierse; Arnold Schmidt; Hubert Scharnagl; Vinzenz Hombach; Wolfgang Koenig
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(2):283-8.
2003: Markus Spaniol; Priska Kaufmann; Konstantin Beier; Jenny Wüthrich; Michael Török; Hubert Scharnagl; Winfried März; Stephan Krähenbühl
Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate.
Journal of lipid research 2003;44(1):144-53.
2001: Hubert Scharnagl; R Schinker; H Gierens; Markus Nauck; Heinrich Wieland; Winfried März
Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells.
Biochemical pharmacology 2001;62(11):1545-55.
2001: Markus S Nauck; W Köster; K Dörfer; J Eckes; Hubert Scharnagl; H Gierens; H Nissen; M A Nauck; Heinrich Wieland; Winfried März
Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia.
Human mutation 2001;18(2):165-6.
2001: Hubert Scharnagl; Markus Nauck; Heinrich Wieland; Winfried März
The Friedewald formula underestimates LDL cholesterol at low concentrations.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(5):426-31.
2001: Winfried März; Hubert Scharnagl; Claudia Abletshauser; Michael M Hoffmann; A Berg; Joseph Keul; Heinrich Wieland; Manfred W Baumstark
Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.
Circulation 2001;103(15):1942-8.
2001: M Hoffmann; Hubert Scharnagl; E Panagiotou; W Banghard; Heinrich Wieland; Winfried März
Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.
Journal of the American Society of Nephrology : JASN 2001;12(3):524-30.
2001: Thomas G Ohm; U Hamker; Angel Cedazo-Minguez; W Röckl; Hubert Scharnagl; W März; Richard Frank Cowburn; W Müller; Volker Meske
Apolipoprotein E and beta A4-amyloid: signals and effects.
Biochemical Society symposium 2001;(67):121-9.
2001: Michael M Hoffmann; Hubert Scharnagl; W Köster; Karl Winkler; Heinrich Wieland; Winfried März
Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia.
Clinica chimica acta; international journal of clinical chemistry 2001;303(1-2):41-8.
2000: Hubert Scharnagl; M Schliack; R Löser; Markus Nauck; H Gierens; Nikola Jeck; Heinrich Wieland; Werner Gross; Winfried März
The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway.
Atherosclerosis 2000;153(1):69-80.
2000: Markus S Nauck; Hubert Scharnagl; H Nissen; C Schürmann; D Matern; M A Nauck; Heinrich Wieland; Winfried März; D Mattern
FH-Freiburg: a novel missense mutation (C317Y) in growth factor repeat A of the low density lipoprotein receptor gene in a German patient with homozygous familial hypercholesterolemia.
Atherosclerosis 2000;151(2):525-34.
2000: Juergen R Schaefer; Karl Winkler; Horst Schweer; Michael M Hoffmann; Muhidien Soufi; Hubert Scharnagl; Bernhard Maisch; Heinrich Wieland; Armin Steinmetz; Winfried März
Increased production of HDL ApoA-I in homozygous familial defective ApoB-100.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1796-9.
2000: H Gierens; Markus Nauck; M Roth; R Schinker; C Schürmann; Hubert Scharnagl; G Neuhaus; Heinrich Wieland; Winfried März
Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1777-83.
2000: Karl Winkler; Juergen R Schaefer; B Klima; C Nuber; Isolde Friedrich; W Köster; H Gierens; Hubert Scharnagl; Muhidien Soufi; Heinrich Wieland; Winfried März
HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia.
Atherosclerosis 2000;150(1):113-20.
1999: Hubert Scharnagl; U Tisljar; Karl Winkler; M Hüttinger; M A Nauck; Werner Gross; Heinrich Wieland; Thomas G Ohm; Winfried März
The betaA4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway.
Laboratory investigation; a journal of technical methods and pathology 1999;79(10):1271-86.
1999: Thomas G Ohm; Hubert Scharnagl; W März; Jürgen R E Bohl
Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Acta neuropathologica 1999;98(3):273-80.
1999: E Fisher; Hubert Scharnagl; Michael M Hoffmann; Klaus Kusterer; D Wittmann; Heinrich Wieland; Werner Gross; Winfried März
Mutations in the apolipoprotein (apo) B-100 receptor-binding region: detection of apo B-100 (Arg3500-->Trp) associated with two new haplotypes and evidence that apo B-100 (Glu3405-->Gln) diminishes receptor-mediated uptake of LDL.
Clinical chemistry 1999;45(7):1026-38.
1999: Klaus Kusterer; T Pohl; H P Fortmeyer; Winfried März; Hubert Scharnagl; A Oldenburg; Sabine Angermüller; Ingrid Fleming; Klaus-H Usadel; Rudi Busse
Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats.
Cardiovascular research 1999;42(3):783-93.
1999: Karl Winkler; Hubert Scharnagl; U Tisljar; H Hoschützky; Isolde Friedrich; Michael M Hoffmann; M Hüttinger; Heinrich Wieland; Winfried März
Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis.
Journal of lipid research 1999;40(3):447-55.
1998: W Müller; Volker Meske; K Berlin; Hubert Scharnagl; W März; Thomas G Ohm
Apolipoprotein E isoforms increase intracellular Ca2+ differentially through a omega-agatoxin IVa-sensitive Ca2+-channel.
Brain pathology (Zurich, Switzerland) 1998;8(4):641-53.
1998: Winfried März; Michael M Hoffmann; Hubert Scharnagl; E Fisher; M Chen; Markus Nauck; Giso Feussner; Heinrich Wieland
Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
Journal of lipid research 1998;39(3):658-69.
1997: Hubert Scharnagl; W März; H Wieland
Lifibrol: first member of a new class of lipid-lowering drugs?
Expert opinion on investigational drugs 1997;6(5):583-91.
1997: Juergen R Schaefer; Hubert Scharnagl; Manfred W Baumstark; Horst Schweer; L A Zech; Hannsjörg W Seyberth; Karl Winkler; Armin Steinmetz; Winfried März
Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(2):348-53.
1996: Giso Feussner; Hubert Scharnagl; C Scherbaum; J Acar; JM Dobmeyer; J Lohrmann; Heinrich Wieland; Winfried März
Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.
Journal of lipid research 1996;37(8):1632-45.
1996: Winfried März; Hubert Scharnagl; UF Mondorf; Heinrich Wieland; Werner Gross; Gerhard Kostner
The receptor-mediated endocytosis of lipoprotein (a).
Zeitschrift für Gastroenterologie 1996;34 Suppl 3():131-8.
1996: Winfried März; Hubert Scharnagl; M Kirça; Jürgen R E Bohl; Werner Gross; Thomas G Ohm
Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation.
Annals of the New York Academy of Sciences 1996;777():276-80.
1995: Thomas G Ohm; M Kirca; Jürgen R E Bohl; Hubert Scharnagl; Werner Gross; Winfried März
Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation.
Neuroscience 1995;66(3):583-7.
1994: S Durovic; Sasa Frank; Hubert Scharnagl; M W Baumstark; Rudolf Zechner; W März; Gerhard Kostner
Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
The Journal of biological chemistry 1994;269(48):30320-5.
1993: Winfried März; M W Baumstark; Hubert Scharnagl; V Ruzicka; S Buxbaum; Jürgen Herwig; T Pohl; A Russ; L Schaaf; A Berg
Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
The Journal of clinical investigation 1993;92(6):2922-33.
1993: Winfried März; R Siekmeier; Hubert Scharnagl; U B Seiffert; Werner Gross
Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins.
Clinical chemistry 1993;39(11 Pt 1):2276-81.
1993: Winfried März; A Beckmann; Hubert Scharnagl; R Siekmeier; UF Mondorf; I Held; W Schneider; K T Preissner; L K Curtiss; Werner Gross
Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
FEBS letters 1993;325(3):271-5.
1990: Winfried März; R Siekmeier; Hubert Scharnagl; Werner Gross
[Fast lipoprotein chromatography: a new method for determining plasma lipoproteins].
Klinische Wochenschrift 1990;68 Suppl 22():114-5.